Background: Infections caused by various microbes may induce immunodeficiency and allergies. Methods: Clinical and laboratory tests were conducted on 579 potentially healthy people (172 women and 407 men, between 25 and 30 years), performed twice: in a diagnosis and after 6 to 12 months. Lymphocytes and NK cells from peripheral blood were assessed using cytometry. G, A, M immunoglobulin concentrations were determined by the turbidimetry. IgE concentration was measured by ELFA. HSV2, HIV and Chlamydia trachomatis infections were detected on the basis of presence of IgM and IgG antibodies tested by ELISA. For the assessment of HPV infections, DNA from the urinary-tract, squamous, and epithelial cells was tested through PCR. The statistical analysis was undertaken using regression analyses. Results: In 579 people in the case of 65 people HPV infections were confirmed 10% men, 14.8% women. In 65 patients, in 1 case concentration of IgA was decreased, in 7 cases IgM. In 21 cases, there were higher concentrations of IgE. During the cytometric analyses a decreased number of T CD31 was found in 3 cases, BCD191 in 5, TCD41 in 5, T CD81 in 4, and NK cells in 8 cases. The check for HSV2 was positive for 17 people: 1.5% men, 6.4% women. In this group in 3 cases the concentration of IgA was decreased; in 2 cases IgM was lowered, in 4 cases there were higher concentrations of IgE. Decreased number of lymphocytes CD191 was observed for 1 person and for 1 person NK cells. Chlamydia trachomatis infections were positive in 10 cases: 1.5% men, 2.3% women; in this group 1 person had lower IgA and 2 persons had increased concentrations of IgE. HIV infection was negative for all the groups. The examination was repeated for 171 out of 579 people after 6 months. HPV infections were positive in 12.9% cases: 14.9% men, 10.8% women; HSV2 in 11 persons: 2.3% men, 10.7% women; Chlamydia trachomatis in 4 cases: 2.3% men 2.4% women. Conclusions: No significant correlation was observed between HPV, HSV2, HIV and Chlamydia trachomatis infections and a relevant deviation from the norm of the investigated immunological parameters. Methods: A 77 year old woman and her 80 year old husband live part of the year in Bolovia where they have kept hives of Africanized honey bees for many years. Neither of them had shown evidence of bee sting hypersensitivity in the past. While tending their hives in a remote area, both were exposed to a massive number of stings (he . 600, she . 200) and barely survived. They are both wondering if they have become sensitized as a result of this event. After discharge from the hospital in Bolivia, she began to experience lethargy and was hospitalized again in Seattle with nausea, vomitting and eosinophilia. Abdominal CT scans showed bilateral adrenal enlargement/masses. Medline, PubMed and Google Scholar searches were performed looking for reports of adrenal insufficiency and bee sting anaphylaxis/ exposure. Results: Evaluation showed evidence of adrenal insufficiency and she has responded to replacement therapy. Subsequent abdominal CT scans have shown shrinkage and involution of both adrenal glands. Both husband and wife were evaluated for stinging insect hypersensitivity and found to be allergic only to honey bee venom and have begun desensitization. They intend to continue to keep honey bees in Seattle but not in Bolivia. Conclusions: A single publication of 3 autopsy studies (Huang, I et al, JACI 1971) looking at venom-specific IgE in tissues showed intense localization in the serum and myocardium in 3 of 3 subjects and adrenal glands in 2 of 3 subjects all of whom died following a single honey bee sting. This would suggest that adrenal insufficiency may be a delayed complication of near-fatal massive envenomation and may play a role in immediate fatal events.
HYMENOPTERA ALLERGY
Background: Evaluations of massive envenomation events have not commonly shown an increased risk for adrenal insufficiency. Methods: A 77 year old woman and her 80 year old husband live part of the year in Bolovia where they have kept hives of Africanized honey bees for many years. Neither of them had shown evidence of bee sting hypersensitivity in the past. While tending their hives in a remote area, both were exposed to a massive number of stings (he . 600, she . 200) and barely survived. They are both wondering if they have become sensitized as a result of this event. After discharge from the hospital in Bolivia, she began to experience lethargy and was hospitalized again in Seattle with nausea, vomitting and eosinophilia. Abdominal CT scans showed bilateral adrenal enlargement/masses. Medline, PubMed and Google Scholar searches were performed looking for reports of adrenal insufficiency and bee sting anaphylaxis/ exposure. Results: Evaluation showed evidence of adrenal insufficiency and she has responded to replacement therapy. Subsequent abdominal CT scans have shown shrinkage and involution of both adrenal glands. Both husband and wife were evaluated for stinging insect hypersensitivity and found to be allergic only to honey bee venom and have begun desensitization. They intend to continue to keep honey bees in Seattle but not in Bolivia. Conclusions: A single publication of 3 autopsy studies (Huang, I et al, JACI 1971) looking at venom-specific IgE in tissues showed intense localization in the serum and myocardium in 3 of 3 subjects and adrenal glands in 2 of 3 subjects all of whom died following a single honey bee sting. This would suggest that adrenal insufficiency may be a delayed complication of near-fatal massive envenomation and may play a role in immediate fatal events. Twenty-eight patients completed the study (16 male were included, with mean 7 6 2.5 years) 15 in the immunotherapy group and 13 in the control group. The immunotherapy group showed a decrease in the diameter of the wheal and flare as well as the duration of the reaction and the use of drugs, from the third month of treatment, compared with the control group (P , 0.001). Conclusions: Our results suggest that immunotherapy with extract of Aedes aegypti, could modify the natural history of LLR to mosquito bites in children. Additional studies are needed to determine the optimal length treatment of the scheme and its long-term effects. Background: As the question of how long VIT should last in order to provide long-term protection is a long-standing issue, we evaluated the specific venom IgE decrease throughout 5-years-long VIT in 3 groups of yellow jacket (YJ) venom-allergic patients: stung during the first 3 years of VIT (SP3), during the last 2 years (SP5) and patients not stung (NS). Methods: We retrospectively evaluated 232 patients submitted to 5-year-long VIT. Specific venom IgE levels were determined at the baseline, after 3 and 5 years of VIT (CAP method, Phadia, Italy). All stung patients were clinically protected. ANOVA analysis evaluated differences among CAPs and in each CAP value among the 3 groups. MANOVA multivariate analysis evaluated differences in overall CAPs and the effects of age, gender, Mueller grade and stings number. A P , 0.05 was considered statistically significant. Data were analysed by 'SPSS' 13.0 (SPSS Inc., Chicago, IL). We called NS patients to check if they were stung after VIT discontinuation. Results: We selected 84 NS, 72 SP3 and 76 SP5 patients. Specific YJ-IgE levels decreased during VIT, as CAPs are statistically different at time 0, 3 and 5 (P , 0.001). Considering CAP levels at the first control (CAP3), NS patients presented lower values than SP3 patients (P ¼ 0.002); no significant difference was found between NS and SP5 patients. At the last control (CAP5), CAP values of NS and SP5 patients were different (P ¼ 0.002) as well as between SP3 and SP5 patients (P ¼ 0.014). No significant difference was found between NS and SP3 patients. By MANOVA, IgE decrease was inversely correlated with Mueller grade (P ¼ 0.012) and age (P ¼ 0.002). We recalled all NS patients by phone, 7/84 (8.3%) patients related one well tolerated sting, as they did not develop any allergic reaction. Conclusions: In everyday practice if a patient never stung during VIT fulfils the temporal criterion, but specific IgE are not negative, a decrease of IgE levels ranging from 57 to 70% in respect to baseline might be a satisfactory parameter for stopping VIT. As a further confirmation of our conclusions, even if not statistically significant, all not stung patients were clinically protected after VIT discontinuation. Background: The worldwide prevalence of allergic reaction to mosquito bites is unknown. Some patients who suffer from local reactions have also systemic symptoms. Methods: A 3 year old female who suffered from mosquitoes bites in her left lower extremity, had a large local reaction with erythema, edema, itching, pain and blisters of 5 · 6 cm. It was accompanied by fever of 38.58C and emesis. She had a positive skin prick test for Aedes aegypti with diagnosis of Skeeter Syndrome. The patient was treated with antihistamine during 10 days and analgesics for 3 days. She was given antihistamine treatment for 10 days and analgesics for 3 days. Results: Skeeter syndrome is defined as a large local reaction induced by mosquito bites associated with systemic symptoms (fever and vomiting) with specific IgE for mosquito identified by skin testing. The primary management of Skeeter syndrome is prevention of mosquito bites, the use of repellents and protective clothing. It is also important the symptomatic management control of pruritus with the use of antihistamines or if necessary topical steroids. Overall children with Skeeter syndrome remain healthy, except for the recurrence of large local reactions to mosquito Stings. Conclusions: The early recognition of Skeeter syndrome is important to give the right management and to prevent unnecessary diagnostic tests and treatments that can increase the risk of adverse reactions and costs. Allergy and Clinical Immunology, Instituto Nacional de Pediatria, Mexico DF. 04530, Mexico. Background: Bee venom immunotherapy is a safe and effective treatment, indicated in patients with previous history of severe systemic reactions to bee venom, demonstrating succesful desensitization in more than 90% of cases with standardized extract. Currently in Mexico there is no standardized extract commercially available for treatment, despite of having high activity of beekeeping and occupational exposure with at least 17,478 registered stings per year and an annually honey production of nearly 70 tons. Methods: We present the clinical progress of 2 patients with history of severe systemic reactions to bee venom and occupational exposure, both with demonstrated sensitization by specific IgE and who underwent specific immunotherapy with standardized extract (Alk-US) reaching a maintenance weekly dose of 100 mcg (PLA 2 ) for the last 4 years. Results: Both patients sufered of accidental stings after reached the maintenance dose presenting mild local reactions to stings. Both patients had very different clinical course presenting a wide variety of adverse reactions during desensitization protocol; from mild local to generalized reactions all generally well tolerated allowed to reach the maintenance dose with succesful desensitization proved by accidental exposure without severe systemic reactions. Conclusions: Bee venom specific immunotherapy with standardized extract is a well tolerated and efective treatment preventing the development of life threathening reactions in sensitized patients. It is important to promote the use and availability of standardized extract in developing countries with poor safety measures and high occupational exposure.
Clinical Case. Bee Venom Anaphylaxis
Adriana Barreto-Sosa, MD, Andrea Aida Velasco-Medina, MD, AndresLeonardo Burbano-Ceron, MD, Aida Gonzalez-Carsolio, MD, and Guillermo Velázquez-Sámano, MD. Servicio de Alergia e Inmunología Clínica, Hospital General de México, Mexico City, Mexico. Background: Skin testing remains the principal confirmatory test for sensitization to hymenopteravenoms. Mechanisms on how venom induces vascular permeability in the skinfollowing intradermal testing are elucidated and how tolerance is induced followinghigh-dose venom exposure. For management, venom immunotherapy remains the mosteffective treatment. Use of immunotherapy in large local reactors to reduce morbidity is discussed. Baseline serum tryptase levels have been identified as one potential markerfor severe systemic reactions to a subsequent sting. Bee venom immunotherapy is effective in most patients immediately after the conventionalmaintenance dose has been reached. In the minority of patients who are not protected withthis dose, an increased maintenance dose will provide appropriate protection immediately after itis achieved usually by 3 to 6 months withstandarding protocols. Thus, the dosage of the maintenance dose seems to be the major factor affectingprotection from re-stings rather than the accumulated venom dose or the durationon the Maintenance Dose. A rush protocol would be recommendedif the patient's risk of being stung againbefore standard immunotherapy could work wereconsidered high. Although immunotherapy is oftenadministered by allergists, it may be deliveredby any practitioner who is willing to observe the patientand to treat anaphylaxis if it should occur. Methods: A 17-year-old man reported being stung by a bee in his workplace. He had been stung several times before, with no clinical manifestations. This last time, he developed face edema, respiratory distress, dyspnea, vomiting recieveing treatment with hydrocortisone. Some time later, he was stung another time, presenting more severe symptoms including dyspnea, stridor, altered mental status, hives, so he was taken to a local clinic where he received epinephrine, dextrose, was hospitalized 4 hours until clinical remission. How should his case be managed subsequently? Results: Intradermal test was positive with a dilution 1:200000.
